ProfileGDS5678 / 1452888_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 7% 3% 3% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.006913
GSM967853U87-EV human glioblastoma xenograft - Control 21.982173
GSM967854U87-EV human glioblastoma xenograft - Control 31.984373
GSM967855U87-EV human glioblastoma xenograft - Control 41.948933
GSM967856U87-EV human glioblastoma xenograft - Control 51.942113
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.014913
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.985633
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.965613
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.961953
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.979883
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.128777
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.965263
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.979453
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.979293